Shams Aammaad 4
4 · Evolent Health, Inc. · Filed Aug 4, 2022
Insider Transaction Report
Form 4
Shams Aammaad
Chief Accounting Officer
Transactions
- Award
Class A Common Stock
2022-08-01+17,247→ 36,884 total
Footnotes (3)
- [F1]Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on August 1, 2023, and 33% on August 1, 2024, and August 1, 2025.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.